Diabetes Board decisions

The Board remands the claims for service connection for diabetes, sleep apnea, prostate cancer, urinary incontinence, residuals of gallbladder removal, gout and low back disability, as well as entitlement to a TDIU prior to April 20, 2023, due to inadequate medical opinions.

The Board remands the claims for service connection for thyroid condition, diabetes, eye condition, and peripheral neuropathy to correct pre-decisional duty to assist errors.

The Board denied an increased rating for diabetes mellitus, type II and granted a 30 percent rating for right upper extremity peripheral neuropathy. The claims for increased ratings for left upper extremity PN, right lower extremity PN, and left lower extremity PN were denied, as was the claim for service connection for hyperlipidemia.

The Board remands the claims for service connection for chronic fatigue syndrome and diabetes mellitus due to an outstanding duty to assist error regarding non-VA treatment records.

The Board remands the claims for service connection for various disabilities, including bilateral hearing loss, tinnitus, heart disability, diabetes mellitus, and neuropathy, to obtain additional evidence and a new medical opinion.

The Board granted service connection for hypothyroidism, diabetes mellitus, type II, and diabetic peripheral neuropathy of the bilateral lower extremities.

The Board granted an effective date of March 2, 2007, for the grant of service connection for left and right lower extremity radiculopathy and November 26, 2014, for COPD, emphysema, and asthma. The claims for earlier effective dates were denied.

The Board granted earlier effective dates for the grant of service connection for DM II, left lower extremity diabetic peripheral neuropathy, and right lower extremity diabetic peripheral neuropathy.

The appeal was dismissed due to the Veteran's death during the pendency of the claims.

The Board granted an initial rating of 40 percent for diabetes mellitus type I, but no higher, for the appeal period prior to February 21, 2018.

The Board dismissed the appeals for earlier effective dates related to various left and right hip, knee, shoulder, and other conditions as they were freestanding claims not continuously pursued from the initial rating decisions.

The Board denied service connection for diabetes type II, peripheral neuropathy of the right and left lower extremities, and neuropathy of the right and left arms. An effective date of May 28, 2020, was granted for the grant of service connection for arteriosclerotic heart disease status post coronary artery bypass graft and atrial fibrillation.

The Board granted service connection for tinnitus, denied service connection for diabetes mellitus, type II and obstructive sleep apnea, and remanded the claim for hypertension.

The Board remands the claims for service connection for right knee disability, diabetes mellitus type II, and voiding dysfunction due to a pre-decisional duty to assist error.

The Board denied the Veteran's claims for service connection for pneumonia and an increased rating for asthma, and remanded several other claims including those for heart condition, chronic low back condition, diabetes mellitus type II, GERD, hypertension, and sleep apnea.

The Board denied the veteran's claims for increased ratings for coronary artery disease, diabetes mellitus type II, obstructive sleep apnea syndrome, peripheral neuropathy of both lower extremities, and left ear hearing loss. The veteran was granted a TDIU.

The Board denied service connection for diabetes mellitus, type II and associated neuropathy of the bilateral upper and lower extremities as there was no evidence establishing a direct or secondary relationship to in-service exposure to contaminated water at Camp Lejeune.

The Board denied an increased rating for bipolar and related disorders, but remanded claims for service connection for hypertension, diabetes, diabetic peripheral neuropathy, and asthma.

The Board granted service connection for the cause of the Veteran's death, finding that his service-connected multiple myeloma contributed substantially and materially to his death.

The Board denied service connection for metabolic syndrome and remanded claims for diabetes, lumbar spine degenerative arthritis, and tension headaches due to insufficient evidence.